Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
ClinicalTrials.gov, 2 Apr 2015
Accessed on 23 Jun 2015 from https://www.clinicaltrials.gov/ct2/show/NCT01405820.